You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
貝康醫療(02170.HK)擬8500萬元收購星博生物51%股權 希冀為集團業務提供協同效應
格隆匯 11-03 12:25

格隆匯11月3日丨貝康醫療(02170.HK)宣佈,於2021年11月3日,星博生物、賣方及公司訂立投資協議,據此,公司同意收購,而賣方同意出售星博生物的51%股權,代價為人民幣8500萬元。星博生物為一家主要專注輔助生殖技術診療產品的研發、生產、銷售和技術服務工作的公司。

收購事項完成後,星博生物將成為公司的非全資附屬公司。代價將以現金支付,並將由集團動用內部資源以全球發售所得款項淨額撥付。

鑑於星博生物戰略性佈局中國生殖遺傳學醫療器械市場的強勁產品組合、強大的研發及市場營銷能力及對中國更廣闊的生殖遺傳市場及整體醫療器械行業擁有豐富經驗及深刻洞察的高級管理團隊,公司對星博生物的前景及發展持樂觀態度。

公司認為,星博生物的業務能夠為集團的業務提供協同效應,且星博生物的產品及在研產品可進一步豐富公司在中國尚未開發市場上的產品供應。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account